Francesco G. Salituro,Albert Jean Robichaud,Gabriel Martinez Botella
申请号：
US15742422
公开号：
US20180201643A1
申请日:
2016.07.06
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof； wherein R1, R2, R3, R4, R5, and R8 are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.
